MedTrace Logo

PFNA vs Dual Mobility in Treatment of Unstable Trochanteric Fractures

NCT05677191 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-01-11

No results posted yet for this study

Summary

Proximal femoral nail \[PFNA\] versus dual mobility arthroplasty in treatment of unstable trochanteric fractures

Conditions

  • Trochanteric Fractures

Interventions

DEVICE

Proximal Femoral Nail

open reduction

COMBINATION_PRODUCT

Dual Mobility Arthroplasty

Hip Arthroplasty Surgery

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-12-31
Completion
2024-12-31
FDA Drug
Yes
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05677191 on ClinicalTrials.gov